{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:19:35Z","timestamp":1785946775668,"version":"3.56.0"},"reference-count":23,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"DOI":"10.1210\/jc.2006-1807","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T02:57:43Z","timestamp":1171421863000},"page":"1606-1612","source":"Crossref","is-referenced-by-count":58,"title":["Familial Partial Lipodystrophy Phenotype Resulting from a Single-Base Mutation in Deoxyribonucleic Acid-Binding Domain of Peroxisome Proliferator-Activated Receptor-\u03b3"],"prefix":"10.1210","volume":"92","author":[{"given":"Houshang","family":"Monajemi","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine (H.M., E.S.), Academic Medical Center, 1150 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology (L.Z., G.L., T.L.), Center for Integrative Metabolic and Endocrine Research, Wayne State University School of Medicine, Detroit, Michigan 48201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology (L.Z., G.L., T.L.), Center for Integrative Metabolic and Endocrine Research, Wayne State University School of Medicine, Detroit, Michigan 48201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen H.","family":"Jeninga","sequence":"additional","affiliation":[{"name":"Department of Metabolic and Endocrine Diseases (E.H.J., E.K.), University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henian","family":"Cao","sequence":"additional","affiliation":[{"name":"Robarts Research Institute and Schulich School of Medicine (H.C., R.A.H.), London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maas","sequence":"additional","affiliation":[{"name":"Radiology (M.M.), Academic Medical Center, 1150 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. B.","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (C.B.B.), Onze Lieve Vrouwe Gasthuis, 1090 HM Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kalkhoven","sequence":"additional","affiliation":[{"name":"Department of Metabolic and Endocrine Diseases (E.H.J., E.K.), University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Stroes","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine (H.M., E.S.), Academic Medical Center, 1150 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[{"name":"Robarts Research Institute and Schulich School of Medicine (H.C., R.A.H.), London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Leff","sequence":"additional","affiliation":[{"name":"Department of Pathology (L.Z., G.L., T.L.), Center for Integrative Metabolic and Endocrine Research, Wayne State University School of Medicine, Detroit, Michigan 48201"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114083717200_R1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1043-2760(03)00142-5","article-title":"Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome.","volume":"14","author":"Hegele","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114083717200_R2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","article-title":"Genetic basis of lipodystrophies and management of metabolic complications.","volume":"57","author":"Agarwal","year":"2006","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t2019041114083717200_R3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state.","volume":"23","author":"Kobberling","year":"1986","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019041114083717200_R4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-\u03b3.","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114083717200_R5","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114083717200_R6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0004.2006.00674.x","article-title":"A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).","volume":"70","author":"Hegele","year":"2006","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t2019041114083717200_R7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-\u03b3 deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med Genet"},{"key":"key\n\t\t\t\t2019041114083717200_R8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPAR\u03b3 associated with severe insulin resistance, diabetes mellitus and hypertension.","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041114083717200_R9","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy.","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114083717200_R10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR \u03b3 is required for the differentiation of adipose tissue in vivo and in vitro.","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t2019041114083717200_R11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR \u03b3 is required for placental, cardiac, and adipose tissue development.","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t2019041114083717200_R12","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1210\/jc.2004-0280","article-title":"A single-base mutation in the peroxisome proliferator-activated receptor \u03b34 promoter associated with altered in vitro expression and partial lipodystrophy.","volume":"89","author":"Al-Shali","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114083717200_R13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/emboj\/17.1.232","article-title":"Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor.","volume":"17","author":"Kalkhoven","year":"1998","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019041114083717200_R14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/MCB.22.7.1961-1970.2002","article-title":"The PHD type zinc finger is an integral part of the CBP acetyltransferase domain.","volume":"22","author":"Kalkhoven","year":"2002","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t2019041114083717200_R15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI117368","article-title":"Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.","volume":"94","author":"Beitel","year":"1994","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114083717200_R16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2001.01323.x","article-title":"Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.","volume":"55","author":"Ruiz","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114083717200_R17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/72777","article-title":"Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.","volume":"24","author":"Haider","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114083717200_R18","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.ophtha.2005.07.002","article-title":"Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity","volume":"112","author":"Hayashi","year":"2005","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t2019041114083717200_R19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199810013391403","article-title":"Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.","volume":"339","author":"Ristow","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114083717200_R20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance.","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t2019041114083717200_R21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/me.2006-0485","article-title":"Impaired PPAR\u03b3 function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.","volume":"21","author":"Jeninga","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041114083717200_R22","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802911","article-title":"Lessons from human mutations in PPAR\u03b3","volume":"29","author":"Hegele","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"key\n\t\t\t\t2019041114083717200_R23","first-page":"33","article-title":"Familial lipoatrophic diabetes with dominant transmission. A new syndrome.","volume":"43","author":"Dunnigan","year":"1974","journal-title":"Q J Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1606\/9051466\/jcem1606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T16:20:09Z","timestamp":1556122809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/5\/1606\/2598033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-1807","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}